


Life Technologies to Present at J.P. Morgan Small/Mid Cap Conference
CARLSBAD, Calif.--([ BUSINESS WIRE ])--Life Technologies Corporation (NASDAQ: LIFE) today announced it will present at the J.P. Morgan Small/Mid-Cap Conference on Friday, December 5, 2008, at 8:45 a.m. EST at the J.P. Morgan Conference Center in New York City. David Hoffmeister, Life Technologies' Chief Financial Officer, will present on behalf of the company. The company will webcast the presentation, which will be available on the Life Technologies' Investor Relations website for approximately 3 weeks following the conference.
About Life Technologies
Life Technologies (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. The company has historical sales of approximately $3.5 billion, employs 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of over 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference please visit our website [ www.lifetechnologies.com ]